Biomolecules and Therapeutics : Impact Factor & More
eISSN: 2005-4483pISSN: 1976-9148
Share this on:
Key Metrics
CiteScore 
8.1
Eigenfactor
0.001 - 0.005
H-Index
49
Impact Factor
< 5
SJR
Q1Biochemistry
SNIP
1.27
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Biomolecules and Therapeutics
Biomolecules and Therapeutics Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | KOREAN SOC APPLIED PHARMACOLOGY |
| Language | English |
| Frequency | Quarterly |
| General Details |
View less
Planning to publish in Biomolecules and Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Biomolecules and Therapeutics
Erratum to "Mechanism of Action and Pharmacokinetics of Approved Bispecific Antibodies" [Biomol Ther 32(6), 708-722 (2024)]
- 1 Nov 2025
- Biomolecules & Therapeutics
DOT1L as a Therapeutic Target: Insights into Epigenetic Regulation and Cancer Treatment
- 31 Oct 2025
- Biomolecules & Therapeutics
CAR-Based Cell and Gene Therapies: Global Clinical Landscape and Emerging Therapeutic Strategies from ClinicalTrials.gov
- 27 Oct 2025
- Biomolecules & Therapeutics
Liposomal Hyaluronic Acid Enhances Skin Permeation and Hydration: Evidence from In Vitro, Ex Vivo, and In Vivo Studies
- 27 Oct 2025
- Biomolecules & Therapeutics
Microglial PLXDC2 Modulates Aβ Phagocytosis and Inflammatory Responses
- 23 Oct 2025
- Biomolecules & Therapeutics
Ursodeoxycholic Acid Attenuates B Cell Susceptibility to SARS-CoV-2 Spike Protein by Interfering Its Binding to ACE2
- 17 Oct 2025
- Biomolecules & Therapeutics
Erratum to "Mechanism of Action and Pharmacokinetics of Approved Bispecific Antibodies" [Biomol Ther 32(6), 708-722 (2024)]
- 1 Nov 2025
- Biomolecules & Therapeutics
DOT1L as a Therapeutic Target: Insights into Epigenetic Regulation and Cancer Treatment
- 31 Oct 2025
- Biomolecules & Therapeutics
CAR-Based Cell and Gene Therapies: Global Clinical Landscape and Emerging Therapeutic Strategies from ClinicalTrials.gov
- 27 Oct 2025
- Biomolecules & Therapeutics
Liposomal Hyaluronic Acid Enhances Skin Permeation and Hydration: Evidence from In Vitro, Ex Vivo, and In Vivo Studies
- 27 Oct 2025
- Biomolecules & Therapeutics
Microglial PLXDC2 Modulates Aβ Phagocytosis and Inflammatory Responses
- 23 Oct 2025
- Biomolecules & Therapeutics
Ursodeoxycholic Acid Attenuates B Cell Susceptibility to SARS-CoV-2 Spike Protein by Interfering Its Binding to ACE2
- 17 Oct 2025
- Biomolecules & Therapeutics
FAQs on Biomolecules and Therapeutics
How long has Biomolecules and Therapeutics been actively publishing? 
What is the publishing frequency of Biomolecules and Therapeutics?
How many articles did Biomolecules and Therapeutics publish last year?
What is the eISSN & pISSN for Biomolecules and Therapeutics?
What is Citescore for Biomolecules and Therapeutics?
What is the H Index for Biomolecules and Therapeutics ?
What is SNIP score for Biomolecules and Therapeutics?
What is the SJR for Biomolecules and Therapeutics?
Who is the publisher of Biomolecules and Therapeutics?
